Lv410
520 积分 2023-04-18 加入
How Feasible Is Docking of PROTACs to POI-E3L Complexes? Testing Physics-Based and ML-Based Docking Tools
9天前
已完结
Discovery and Optimization of a Non-Nucleoside-Based Series of Inhibitors of 2′-Deoxynucleoside 5′-Monophosphate Glycosidase (DNPH1)
15天前
已完结
Big pharma seduced by transcription factors again. What has changed?
16天前
已完结
14-3-3 sigma increases the transcriptional activity of the androgen receptor in the absence of androgens
17天前
已完结
Structural and Physicochemical Features of Oral PROTACs
17天前
已完结
Discovery of Highly Potent and Orally Available CCNK Molecular Glue Degraders as Broad-Spectrum Antitumor Agents
18天前
已完结
Innovative Medicinal Chemistry Strategies for Improving Target Binding Kinetics in Drug Discovery
18天前
已完结
The Logic of Chemical Optimization
19天前
已完结
Discovery of a Highly Potent, N-terminal Domain-targeting degrader of AR-FL/AR-V7 for the treatment of Prostate Cancer
22天前
已完结
The IRβ/HCF-1/ChREBP axis: A new paradigm in insulin-regulated hepatic lipogenesis
22天前
已完结
皖公网安备34019202002308
